Therapeutic drug monitoring of piperacillin-tazobactam using spent dialysate effluent in patients receiving continuous venovenous hemodialysis.
about
Clinical Validation of Therapeutic Drug Monitoring of Imipenem in Spent Effluent in Critically Ill Patients Receiving Continuous Renal Replacement Therapy: A Pilot StudySuccessful delivery of RRT in Ebola virus diseaseTherapeutic drug monitoring of antimicrobials.Pharmacokinetics and pharmacodynamics of piperacillin-tazobactam in 42 patients treated with concomitant CRRT.Does Beta-lactam Pharmacokinetic Variability in Critically Ill Patients Justify Therapeutic Drug Monitoring? A Systematic Review.Pharmacokinetics and Pharmacodynamics of Extended Infusion Versus Short Infusion Piperacillin-Tazobactam in Critically Ill Patients Undergoing CRRT.Pharmacokinetics and outcome of tazobactam/piperacillin in Japanese patients undergoing low-flow continuous renal replacement therapy: dosage considerations.Pharmacokinetic assessment in patients receiving continuous RRT: perspectives from the Kidney Health Initiative.Staying on target with continuous dialysis.Use of therapeutic drug monitoring to treat Elizabethkingia meningoseptica meningitis and bacteraemia in an adult.Piperacillin-tazobactam as alternative to carbapenems for ICU patients.Risk factors for target non-attainment during empirical treatment with β-lactam antibiotics in critically ill patients.Elimination Rates of Electrolytes, Vitamins, and Trace Elements during Continuous Renal Replacement Therapy with Citrate Continuous Veno-Venous Hemodialysis: Influence of Filter Lifetime.
P2860
Q28551453-4212374F-518D-4500-83AB-BF00166517F5Q34787843-BC1F94D6-E248-499D-8430-E04825643BF9Q35640430-2827BC75-98EF-4277-A4A9-D7E238636ECCQ35827280-93C7EBCD-FDC1-4837-93A2-4D80B36F1F15Q36287127-75CA3BEC-0EF2-4C74-8C42-3B3050CD421BQ38838763-17F9D564-124B-44B5-974F-D1A4CBBB47EFQ38916254-610D11E4-2A1C-453F-AB26-83498C92812CQ41819424-7F74848D-0FAA-454D-8E4E-F8021F956CA1Q42907574-2FEF1D55-150D-45F7-B360-CA5AEA2DBA0CQ43169888-5DF5BA74-35A1-46BB-8251-F6B733AC30DFQ45711115-34837934-5F9B-44F1-A803-985C0F61E02BQ49056677-406E73D3-7E06-4C8B-86F6-18546688A15CQ54751365-1E3C5EEA-0652-4C25-BB0E-A07FB6C621E2
P2860
Therapeutic drug monitoring of piperacillin-tazobactam using spent dialysate effluent in patients receiving continuous venovenous hemodialysis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Therapeutic drug monitoring of ...... nuous venovenous hemodialysis.
@ast
Therapeutic drug monitoring of ...... nuous venovenous hemodialysis.
@en
Therapeutic drug monitoring of ...... nuous venovenous hemodialysis.
@nl
type
label
Therapeutic drug monitoring of ...... nuous venovenous hemodialysis.
@ast
Therapeutic drug monitoring of ...... nuous venovenous hemodialysis.
@en
Therapeutic drug monitoring of ...... nuous venovenous hemodialysis.
@nl
prefLabel
Therapeutic drug monitoring of ...... nuous venovenous hemodialysis.
@ast
Therapeutic drug monitoring of ...... nuous venovenous hemodialysis.
@en
Therapeutic drug monitoring of ...... nuous venovenous hemodialysis.
@nl
P2093
P2860
P356
P1476
Therapeutic drug monitoring of ...... nuous venovenous hemodialysis.
@en
P2093
Charbel Salem
Christina L Hofmann
Joseph Groszek
Michael J Connor
Robert Butler
Seth R Bauer
Susan J Rehm
William H Fissell
P2860
P304
P356
10.1128/AAC.00548-10
P407
P577
2010-11-29T00:00:00Z